Profound Medical (PROF) Income towards Parent Company (2024 - 2026)

Profound Medical's Income towards Parent Company history runs 3 years deep, the most recent figure standing at -$7.1 million for Q1 2026.

• On a quarterly basis, Income towards Parent Company rose 34.21% year-over-year to -$7.1 million in Q1 2026; TTM through Mar 2026 was -$38.9 million, a 7848.01% decrease from a year earlier, with the FY2025 full-year figure at -$42.5 million, down 1016.81% from the prior year.
• Income towards Parent Company grew to -$7.1 million in Q1 2026 per PROF's latest filing, from -$8.2 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at $27.5 million in Q4 2024 and bottomed at -$15.7 million in Q2 2025.
• The 3-year median for Income towards Parent Company is -$8.0 million (2025), against an average of -$5.0 million.
• Across the five-year window, Income towards Parent Company tumbled 129.64% in 2025 and surged 34.21% in 2026, its largest moves.
• Year by year, Income towards Parent Company stood at $27.5 million in 2024, then tumbled by 129.64% to -$8.2 million in 2025, then grew by 13.48% to -$7.1 million in 2026.
• Per Business Quant, the three latest PROF Income towards Parent Company figures stand at -$7.1 million (Q1 2026), -$8.2 million (Q4 2025), and -$8.0 million (Q3 2025).